Interactions between chemokine and mu-opioid receptors: Anatomical findings and electrophysiological studies in the rat periaqueductal grey

Brain, Behavior, and Immunity

Volumn 25, Issue 2, 2011, Pages 360-372

  Heinisch, Silke ^a   Palma, Jonathan ^a   Kirby, Lynn G ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CX3CR1; CXCR4; Electrophysiology; Fractalkine CX3CL1; Heterologous desensitization; Immunohistochemistry; Morphine; Mu opioid receptor; Periaqueductal grey; SDF 1 CXCL12

Indexed keywords

CHEMOKINE RECEPTOR CX3CR1; CHEMOKINE RECEPTOR CXCR4; FRACTALKINE; MORPHINE; MU OPIATE RECEPTOR; STROMAL CELL DERIVED FACTOR 1ALPHA;

ANIMAL EXPERIMENT; ARTICLE; CINGULATE GYRUS; HIPPOCAMPUS; HYPERPOLARIZATION; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; RECEPTOR DOWN REGULATION;

ANIMALS; ANTIBODIES; BRAIN CHEMISTRY; CEREBRAL CORTEX; CHEMOKINES; ELECTROPHYSIOLOGICAL PHENOMENA; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE POTENTIALS; MICROSCOPY, FLUORESCENCE; NEURONS; PATCH-CLAMP TECHNIQUES; PERIAQUEDUCTAL GRAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CHEMOKINE; RECEPTORS, CXCR4; RECEPTORS, OPIOID, MU;

EID: 78651440933     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2010.10.020     Document Type: Article

References (75)

1. Alger B.E. Characteristics of a slow hyperpolarizing synaptic potential in rat hippocampal pyramidal cells in vitro. J. Neurophysiol. 1984, 52:892-910.
2. Araque A., Parpura V., Sanzgiri R.P., Haydon P.G. Glutamate-dependent astrocyte modulation of synaptic transmission between cultured hippocampal neurons. Eur. J. Neurosci. 1998, 10:2129-2142.
3. Arvidsson U., Riedl M., Chakrabarti S., Lee J.H., Nakano A.H., Dado R.J., Loh H.H., Law P.Y., Wessendorf M.W., Elde R. Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord. J. Neurosci. 1995, 15:3328-3341.
4. Azmitia E.C., Whitaker-Azmitia P.M. Awakening the sleeping giant: anatomy and plasticity of the brain serotonergic system. J. Clin. Psychiatry 1991, 52:4-16.
5. Bandler R., Shipley M.T. Columnar organization in the midbrain periaqueductal gray: modules for emotional expression?. Trends Neurosci. 1994, 17:379-389.
6. Banisadr G., Fontanges P., Haour F., Kitabgi P., Rostene W., Melik P.S. Neuroanatomical distribution of CXCR4 in adult rat brain and its localization in cholinergic and dopaminergic neurons. Eur. J. Neurosci. 2002, 16:1661-1671.
7. Bertollini C., Ragozzino D., Gross C., Limatola C., Eusebi F. Fractalkine/CX3CL1 depresses central synaptic transmission in mouse hippocampal slices. Neuropharmacology 2006, 51:816-821.
8. Chen C., Li J., Bot G., Szabo I., Rogers T.J., Liu-Chen L.Y. Heterodimerization and cross-desensitization between the mu-opioid receptor and the chemokine CCR5 receptor. Eur. J. Pharmacol. 2004, 483:175-186.
9. Chen X., Geller E.B., Rogers T.J., Adler M.W. The chemokine CX3CL1/fractalkine interferes with the antinociceptive effect induced by opioid agonists in the periaqueductal grey of rats. Brain Res. 2007, 1153:52-57.
10. Chieng B., Christie M.J. Hyperpolarization by opioids acting on mu-receptors of a sub-population of rat periaqueductal gray neurons in vitro. Br. J. Pharmacol. 1994, 113:121-128.
11. + channels by nociceptin and a mu-opioid in rat periaqueductal grey slices. Naunyn Schmiedebergs Arch. Pharmacol. 2001, 363:583-589.
12. + channels and cellular actions of morphine in periaqueductal gray slices of neonatal and adult rats. J. Pharmacol. Exp. Ther. 2001, 298:493-500.
13. Coughlan C.M., McManus C.M., Sharron M., Gao Z., Murphy D., Jaffer S., Choe W., Chen W., Hesselgesser J., Gaylord H., Kalyuzhny A., Lee V.M., Wolf B., Doms R.W., Kolson D.L. Expression of multiple functional chemokine receptors and monocyte chemoattractant protein-1 in human neurons. Neuroscience 2000, 97:591-600.
14. D'Ambrosio D., Panina-Bordignon P., Sinigaglia F. Chemokine receptors in inflammation: an overview. J. Immunol. Methods 2003, 273:3-13.
15. Fecho K., Maslonek K.A., Dykstra L.A., Lysle D.T. Assessment of the involvement of central nervous system and peripheral opioid receptors in the immunomodulatory effects of acute morphine treatment in rats. J. Pharmacol. Exp. Ther. 1996, 276:626-636.
16. Fedyk E.R., Ryyan D.H., Ritterman I., Springer T.A. Maturation decreases responsiveness of human bone marrow B lineage cells to stromal-derived factor 1 (SDF-1). J. Leukoc. Biol. 1999, 66:667-673.
17. Fischer T., Nagel F., Jacobs S., Stumm R., Schulz S. Reassessment of CXCR4 chemokine receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-2. PLoS One 2008, 3:e4069.
18. Gibb A.J., Edwards F.A. Patch clamp recording from cells in sliced tissues. Microelectrode Techniques. The Plymouth Workshop Handbook 1994, 255-274. The Company of Biologists Limited, Cambridge. D. Ogden (Ed.).
19. Glabinski A.R., Ransohoff R.M. Chemokines and chemokine receptors in CNS pathology. J. Neurovirol. 1999, 5:3-12.
20. Gosselin R.D., Dansereau M.A., Pohl M., Kitabgi P., Beaudet N., Sarret P., Melik Parsadaniantz S. Chemokine network in the nervous system: a new target for pain relief. Curr. Med. Chem. 2008, 15:2866-2875.
21. Grimm M.C., Ben-Baruch A., Taub D.D., Howard O.M., Resau J.H., Wang J.M., Ali H., Richardson R., Snyderman R., Oppenheim J.J. Opiates transdeactivate chemokine receptors: delta and mu opiate receptor-mediated heterologous desensitization. J. Exp. Med. 1998, 188:317-325.
22. Guyon A., Skrzydelsi D., Rovère C., Rostène W., Parsadaniantz S.M., Nahon J.L. Stromal cell-derived factor-1alpha modulation of the excitability of rat substantia nigra dopaminergic neurones: presynaptic mechanisms. J. Neurochem. 2006, 96:1540-1550.
23. Guyon A., Nahon J.L. Multiple actions of the chemokine stromal cell-derived factor-1α on neuronal activity. J. Mol. Endocrinol. 2007, 38:365-376.
24. Guyon A., Skrzydelski D., Rovère C., Apartis E., Rostène W., Kitabgi P., Mélik Parsadaniantz S., Nahon J.L. Stromal-cell-derived factor 1alpha/CXCL12 modulates high-threshold calcium currents in rat substantia nigra. Eur. J. Neurosci. 2008, 28:862-870.
25. + channel and 5-hydroxytryptamine 1A autoreceptor interactions in the rat dorsal raphe nucleus: an in vitro electrophysiological study. Neuroscience 1991, 41:495-500.
26. Harrison J.K., Jiang Y., Chen S., Xia Y., Maciejewski D., McNamara R.K., Streit W.J., Salafranca M.N., Adhikari S., Thompson D.A., Botti P., Bacon K.B., Feng L. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc. Natl. Acad. Sci. USA 1998, 95:10896-10901.
27. Hauser K.F., Mangoura D. Diversity of the endogenous opioid system in development. Novel signal transduction translates multiple extracellular signals into neural cell growth and differentiation. Perspect. Dev. Neurobiol. 1998, 5:437-449.
28. Heinisch S., Kirby L.G. Fractalkine/CX3CL1 enhances GABA synaptic activity at serotonin neurons in the rat dorsal raphe nucleus. Neuroscience 2009, 164:1210-1223.
29. Heinisch S., Kirby L.G. SDF-1α/CXCL12 enhances GABA and glutamate synaptic activity at serotonin neurons in the rat dorsal raphe nucleus. Neuropharmacology 2010, 58:501-514.
30. Hernandez M.C., Flores L.R., Bayer B.M. Immunosuppression by morphine is mediated by central pathways. J. Pharmacol. Exp. Ther. 1993, 267:1336-1341.
31. Hesselgesser J., Liang M., Hoxie J., Greenberg M., Brass L.F., Orsini M.J., Taub D., Horuk R. Identification and characterization of the CXCR4 chemokine receptor in human T cell lines: ligand binding, biological activity, and HIV-1 infectivity. J. Immunol. 1998, 160:877-883.
32. Horuk R., Martin A.W., Wang Z., Schweitzer L., Gerassimides A., Guo H., Lu Z., Hesselgesser J., Perez H.D., Kim J., Parker J., Hadley T.J., Peiper S.C. Expression of chemokine receptors by subsets of neurons in the central nervous system. J. Immunol. 1997, 158:2882-2890.
33. Hughes P.M., Botham M.S., Frentzel S., Mir A., Perry V.H. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS. Glia 2002, 37:314-327.
34. Imai T., Hieshima K., Haskell C., Baba M., Nagira M., Nishimura M., Kakizaki M., Takagi S., Nomiyama H., Schall T.J., Yoshie O. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 1997, 91:521-530.
35. Karuppagounder S.S., Shi Q., Xu H., Gibson G.E. Changes in inflammatory processes associated with selective vulnerability following mild impairment of oxidative metabolism. Neurobiol. Dis. 2007, 26:353-362.
36. Limatola C., Giovannelli A., Maggi L., Ragozzino D., Castellani L., Ciotti M.T., Vacca F., Mercanti D., Santoni A., Eusebi F. SDF-1alpha-mediated modulation of synaptic transmission in rat cerebellum. Eur. J. Neurosci. 2000, 12:2497-2504.
37. Limatola C., Lauro C., Catalano M., Ciotti M.T., Bertollini C., Di Angelantonio S., Ragozzino D., Eusebi F. Chemokine CX3CL1 protects rat hippocampal neurons against glutamate-mediated excitotoxicity. J. Neuroimmunol. 2005, 166:19-28.
38. Liu Y., Blackbourn D.J., Chuang L.F., Killam K.F., Chuang R.Y. Effects of in vivo and in vitro administration of morphine sulfate upon rhesus macaque 180 polymorphonuclear cell phagocytosis and chemotaxis. J. Pharmacol. Exp. Ther. 1992, 263:533-539.
39. Lorenzo P., Portolés A., Beneit J.V., Ronda E., Portolés A. Physical dependence to morphine diminishes the interferon response in mice. Immunopharmacology 1987, 14:93-99.
40. Lu M., Grove E.A., Miller R.J. Abnormal development of the hippocampal dentate gyrus in mice lacking the CXCR4 chemokine receptor. Proc. Natl. Acad. Sci. USA 2002, 99:7090-7095.
41. Maciejewski-Lenoir D., Chen S., Feng L., Maki R., Bacon K.B. Characterization of fractalkine in rat brain cells: migratory and activation signals for CX3CR-1-expressing microglia. J. Immunol. 1999, 163:1628-1635.
42. Mansour A., Fox C.A., Burke S., Akil H., Watson S.J. Immunohistochemical localization of the cloned mu opioid receptor in the rat CNS. J. Chem. Neuroanat. 1995, 8:283-305.
43. Mennicken F., Maki R., de Souza E.B., Quirion R. Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning. Trends Pharm. Sci. 1999, 20:73-78.
44. Meucci O., Fatatis A., Simen A.A., Bushell T.J., Gray P.W., Miller R.J. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc. Natl. Acad. Sci. USA 1998, 95:14500-14505.
45. Meucci O., Fatatis A., Simen A.A., Miller R.J. Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc. Natl. Acad. Sci. USA 2000, 97:8075-8080.
46. Mizuno T., Kawanokuchi J., Numata K., Suzumura A. Production and neuroprotective functions of fractalkine in the central nervous system. Brain Res. 2003, 979:65-70.
47. Moon S.O., Kim W., Sung M.J., Lee S., Kang K.P., Kim D.H., Lee S.Y., So J.N., Park S.K. Resveratrol suppresses tumor necrosis factor-alpha-induced fractalkine expression in endothelial cells. Mol. Pharmacol. 2006, 70:112-119.
48. Nishiyori A., Minami M., Ohtani Y., Takami S., Yamamoto J., Kawaguchi N., Kume T., Akaike A., Satoh M. Localization of fractalkine and CX3CR1 mRNAs in rat brain: does fractalkine play a role in signaling from neuron to microglia?. FEBS Lett. 1998, 429:167-172.
49. Patel J.P., Sengupta R., Bardi G., Khan M.Z., Mullen-Przeworski A., Meucci O. Modulation of neuronal CXCR4 by the micro-opioid agonist DAMGO. J. Neurovirol. 2006, 12:492-500.
50. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 2005, Academic Press, New York.
51. Pujol F., Kitabgi P., Boudin H. The chemokine SDF-1 differentially regulates axonal elongation and branching in hippocampal neurons. J. Cell Sci. 2005, 118:1071-1080.
52. Ragozzino D., Di A.S., Trettel F., Bertollini C., Maggi L., Gross C., Charo I.F., Limatola C., Eusebi F. Chemokine fractalkine/CX3CL1 negatively modulates active glutamatergic synapses in rat hippocampal neurons. J. Neurosci. 2006, 26:10488-10498.
53. Ragozzino D., Renzi M., Giovannelli A., Eusebi F. Stimulation of chemokine CXC receptor 4 induces synaptic depression of evoked parallel fibers inputs onto Purkinje neurons in mouse cerebellum. J. Neuroimmunol. 2002, 127:30-36.
54. Schmidtmayerova H., Sherry B., Bukrinsky M. Chemokines and HIV replication. Nature 1996, 382:767.
55. Skrzydelski D., Guyon A., Dauge V., Rovere C., Apartis E., Kitabgi P., Nahon J.L., Rostene W., Parsadaniantz S.M. The chemokine stromal cell-derived factor-1/CXCL12 activates the nigrostriatal dopamine system. J. Neurochem. 2007, 102:1175-1183.
56. Sørensen T.L., Tani M., Jensen J., Pierce V., Lucchinetti C., Folcik V.A., Qin S., Rottman J., Sellebjerg F., Strieter R.M., Frederiksen J.L., Ransohoff R.M. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J. Clin. Invest. 1999, 103:807-815.
57. Sprenger H., Rösler A., Tonn P., Braune H.J., Huffmann G., Gemsa D. Chemokines in the cerebrospinal fluid of patients with meningitis. Clin. Immunol. Immunopathol. 1996, 80:155-161.
58. Starec M., Rouveix B., Sinet M., Chau F., Desforges B., Pocidalo J.J., Lechat P. Immune status and survival of opiate- and cocaine-treated mice infected with Friend virus. J. Pharmacol. Exp. Ther. 1991, 259:745-750.
59. Steele A.D., Szabo I., Bednar F., Rogers T.J. Interactions between opioid and chemokine receptors: heterologous desensitization. Cytokine Growth Factor Rev. 2002, 13:209-222.
60. Stefano G.B., Scharrer B., Smith E.M., Hughes T.K., Magazine H.I., Bilfinger T.V., Hartman A.R., Fricchione G.L., Liu Y., Makman M.H. Opioid and opiate immunoregulatory processes. Crit. Rev. Immunol. 1996, 16:109-144.
61. Stumm R., Hollt V. CXC chemokine receptor 4 regulates neuronal migration and axonal pathfinding in the developing nervous system: implications for neuronal regeneration in the adult brain. J. Mol. Endocrinol. 2007, 38:377-382.
62. Stumm R., Kolodziej A., Schulz S., Kohtz J.D., Hollt V. Patterns of SDF-1alpha and SDF-1gamma mRNAs, migration pathways, and phenotypes of CXCR4-expressing neurons in the developing rat telencephalon. J. Comp. Neurol. 2007, 502:382-399.
63. Stumm R.K., Rummel J., Junker V., Culmsee C., Pfeiffer M., Krieglstein J., Hollt V., Schulz S. A dual role for the SDF-1/CXCR4 chemokine receptor system in adult brain: isoform-selective regulation of SDF-1 expression modulates CXCR4-dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia. J. Neurosci. 2002, 22:5865-5878.
64. Stumm R.K., Zhou C., Ara T., Lazarini F., Dubois-Dalcq M., Nagasawa T., Hollt V., Schulz S. CXCR4 regulates interneuron migration in the developing neocortex. J. Neurosci. 2003, 23:5123-5130.
65. Szabo I., Wetzel M., McCarthy L., Steele A., Henderson E.E., Howard M.Z., Oppenheim J.J., Rogers T.J. Interactions of opioid receptors, chemokines, and chemokine receptors. Adv. Exp. Med. Biol. 2001, 493:69-74.
66. Szabo I., Chen X.H., Xin L., Adler M.W., Howard O.M., Oppenheim J.J., Rogers T.J. Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain. Proc. Natl. Acad. Sci. USA 2002, 99:10276-10281.
67. Szabo I., Wetzel M.A., Zhang N., Steele A.D., Kaminsky D.E., Chen C., Liu-Chen L.Y., Bednar F., Henderson E.E., Howard O.M., Oppenheim J.J., Rogers T.J. Selective inactivation of CCR5 and decreased infectivity of R5 HIV-1 strains mediated by opioid-induced heterologous desensitization. J. Leuk. Biol. 2003, 74:1074-1082.
68. Tran P.B., Miller R.J. Chemokine receptors: signposts to brain development and disease. Nat. Rev. Neurosci. 2003, 4:444-455.
69. Tran P.B., Banisadr G., Ren D., Chenn A., Miller R.J. Chemokine receptor expression by neural progenitor cells in neurogenic regions of mouse brain. J. Comp Neurol. 2007, 500:1007-1033.
70. Trecki J., Brailoiu G.C., Unterwald E.M. Localization of CXCR4 in the forebrain of the adult rat. Brain Res. 2010, 1315:53-62.
71. Vandermaelen C.P., Aghajanian G.K. Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices. Brain Res. 1983, 289:109-119.
72. Vaughan C.W., Christie M.J. Presynaptic inhibitory action of opioids on synaptic transmission in the rat periaqueductal grey in vitro. J. Physiol. 1997, 498:463-472.
73. Verge G.M., Milligan E.D., Maier S.F., Watkins L.R., Naeve G.S., Foster A.C. Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions. Eur. J. Neurosci. 2004, 20:1150-1160.
74. Wang H., Moriwaki A., Wang J.B., Uhl G.R., Pickel V.M. Ultrastructural immunocytochemical localization of mu opioid receptors and Leu5-enkephalin in the patch compartment of the rat caudate-putamen nucleus. J. Comp. Neurol. 1996, 375:659-674.
75. Zhang N., Rogers T.J., Caterina M., Oppenheim J.J. Proinflammatory chemokines, such as C-C chemokine ligand 3, desensitize mu-opioid receptors on dorsal root ganglia neurons. J. Immunol. 2004, 173:594-599.